【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Vaccine approval process
• Vaccines price list
PART 06: Pipeline portfolio
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by type of human vaccine
• Live attenuated vaccine
• Killed vaccine
• Toxoid vaccine
• Genetically modified/engineered vaccine
• Synthetic vaccines
• Dendritic cells vaccines
• Conjugate vaccines
• Subunit vaccines
PART 09: Market segmentation by composition
• Mono vaccine
• Combination vaccines
PART 10: Market segmentation by route of administration
• Oral vaccines
• Intramuscular vaccines
• Intranasal vaccines
• Intradermal vaccines
PART 11: Market segmentation by type of human vaccine
PART 12: Global therapeutic human vaccines market
• Market overview
• Market size and forecast
PART 13: Global preventable human vaccines market
• Market overview
• Market size and forecast
PART 14: Global pediatric preventable human vaccines market
• Market size and forecast
PART 15: Global adult preventable human vaccines market
• Market size and forecast
PART 16: Geographical segmentation
• Human vaccines market in the Americas
• Market size and forecast
• Human vaccines market in EMEA
• Market size and forecast
• Human vaccines market in APAC
• Market size and forecast
PART 17: Market drivers
• Growing awareness about vaccination and immunization programs
• Inclusion in national immunization schedule
• High demand for pediatric vaccines
• Increase in prevalence of infectious diseases
PART 18: Impact of drivers
PART 19: Market challenges
• Inadequate vaccination coverage
• Vaccine storage and handling issues
• High risk associated with vaccine development
• Stringent regulatory process
• Misperception about vaccines
• Adverse side effects of vaccines
PART 20: Impact of drivers and challenges
PART 21: Market trends
• Increase in strategic alliance and M&A
• Entry of novel vaccines
• Increase in investment
• Focus on emerging markets
• Emergence of resistant strains
• Public-private initiatives
PART 22: Vendor landscape
• Competitive scenario
PART 23: Key vendor analysis
• GSK
• Sanofi
• Merck
• Pfizer
• Other prominent vendors
PART 24: Appendix
• List of abbreviations
PART 25: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Requirements for BLA submission in the US
Exhibit 03: Developmental steps required to reach the vaccine licensing stage
Exhibit 04: Vaccine development process over a period of up to 15 years at a cost of up to $1 billion
Exhibit 05: Regulatory testing of licensed vaccines
Exhibit 06: Pediatric/VFC vaccine price list
Exhibit 07: Pediatric influenza vaccine price list
Exhibit 08: Adult vaccine price list
Exhibit 09: Adult influenza vaccine price list
Exhibit 10: GlaxoSmithKline: Vaccine pipeline
Exhibit 11: Novartis: Vaccine pipeline
Exhibit 12: Merck: vaccine pipeline
Exhibit 13: Pfizer: vaccine pipeline
Exhibit 14: Sanofi: vaccine pipeline
Exhibit 15: TuBerculosis Vaccine Initiative (TBVI): vaccine pipeline
Exhibit 16: Some pipeline compounds under development in 2015
Exhibit 17: Top 10 pharmaceutical companies based on global vaccine revenues in 2014 ($ millions)
Exhibit 18: Global human vaccines market 2015-2020 ($ billions)
Exhibit 19: SWOT analysis
Exhibit 20: Five forces analysis
Exhibit 21: Global human vaccines market segmentation by type of vaccine
Exhibit 22: Examples of vaccines by type
Exhibit 23: Global human vaccines market segmentation by composition
Exhibit 24: Global human vaccines market segmentation by route of administration
Exhibit 25: Route of administration for different vaccines
Exhibit 26: Global human vaccines market types
Exhibit 27: Global preventable and therapeutic human vaccines market share 2015
Exhibit 28: Global therapeutic human vaccines market 2015-2020 ($ billions)
Exhibit 29: Global preventable human vaccines market 2015-2020 ($ billions)
Exhibit 30: Global preventable human vaccines market categories
Exhibit 31: Global pediatric and adult preventable human vaccines market share 2015
Exhibit 32: Global pediatric preventable human vaccines market segmentation 2015
Exhibit 33: Global pediatric preventable human vaccines market 2015-2020 ($ billions)
Exhibit 34: Global adult preventable human vaccines market share 2015
Exhibit 35: Global adult preventable human vaccines market 2015-2020 ($ billions)
Exhibit 36: Global human vaccines market by geography 2015
Exhibit 37: Global human vaccines market by region 2015-2020 ($ billions)
Exhibit 38: Human vaccines market in the Americas 2015-2020 ($ billions)
Exhibit 39: Human vaccines market in EMEA 2015-2020 ($ billions)
Exhibit 40: Human vaccines market in APAC 2015-2020 ($ billions)
Exhibit 41: Impact of drivers
Exhibit 42: Global immunization coverage 2014
Exhibit 43: A typical cold chain process
Exhibit 44: Adverse effects associated with some preventable human vaccines
Exhibit 45: Impact of drivers and challenges
Exhibit 46: M&A in the vaccine industry
Exhibit 47: Overview of major vaccine-related acquisitions (2005-2012)
Exhibit 48: Market share analysis of top pharma vaccine companies, 2014
Exhibit 49: GSK: Business segmentation by revenue 2014
Exhibit 50: GSK: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 51: GSK: Geographical segmentation by revenue 2014
Exhibit 52: GSK: YoY revenue growth of Infanrix/Pediarix 2012-2014 ($ millions)
Exhibit 53: GSK: YoY revenue growth of Hepatitis vaccine 2012-2014 ($ millions)
Exhibit 54: GSK: YoY revenue growth of Synflorix 2012-2014 ($ millions)
Exhibit 55: GSK: YoY revenue growth of Rotarix 2012-2014 ($ millions)
Exhibit 56: GSK: YoY revenue growth of Boostrix 2012-2014 ($ millions)
Exhibit 57: GSK: Meningitis vaccine revenue 2013 and 2014 ($ millions)
Exhibit 58: GSK: Travel and paediatrics vaccine revenue 2013 and 2014 ($ millions)
Exhibit 59: Key takeaways
Exhibit 60: Sanofi: Business segmentation by revenue 2014
Exhibit 61: Sanofi: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 62: Sanofi: Geographical segmentation by revenue 2014
Exhibit 63: Sanofi: YoY revenue growth of Polio/pertussis/Hib vaccines ($ millions)
Exhibit 64: Sanofi: YoY revenue growth of influenza vaccines 2012-2014 ($ millions)
Exhibit 65: Sanofi: YoY revenue growth of meningitis/pneumonia vaccine 2012-2014 ($ millions)
Exhibit 66: Sanofi: YoY revenue growth of adult booster vaccine 2012-2014 ($ millions)
Exhibit 67: Sanofi: YoY revenue growth of travel and other endemic vaccines 2012-2014 ($ millions)
Exhibit 68: Key takeaways
Exhibit 69: Merck: Business segmentation by revenue 2014
Exhibit 70: Merck: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 71: Merck: Geographical segmentation by revenue 2014
Exhibit 72: Merck: YoY revenue growth of Gardasil 2012-2014 ($ millions)
Exhibit 73: Merck: YoY revenue growth of ProQuad/MMR II/Varivax 2012-2014 ($ millions)
Exhibit 74: Merck: YoY revenue growth of Zostavax 2012-2014 ($ millions)
Exhibit 75: Merck: YoY revenue growth of Pneumovax 23 2012-2014 ($ millions)
Exhibit 76: Merck: YoY revenue growth of RotaTeq 2012-2014 ($ millions)
Exhibit 77: Key takeaways
Exhibit 78: Pfizer: Business segmentation by revenue 2014 0
Exhibit 79: Pfizer: Business segmentation by revenue 2013 and 2014 ($ billions) 1
Exhibit 80: Pfizer: Geographical segmentation by revenue 2014 2
Exhibit 81: Pfizer: YoY revenue growth of Prevnar family 2012-2014 ($ millions) 3
Exhibit 82: Key takeaways
【レポート販売概要】
■ タイトル：ワクチンの世界市場2016-2020■ 英文：Global Human Vaccine Market 2016-2020
■ 発行日：2016年1月20日
■ 調査会社：Technavio
■ 商品コード：IRTNTR8142
■ 調査対象地域：グローバル
- 一回用バイオプロセスシステムの世界市場2015-2019About Single-use Bioprocessing System Single-use bioprocessing technology is a rapidly evolving technology that focuses on developing disposable bioprocessing equipment and accessories for manufacturing biopharmaceutical products. Bioprocess is the process that utilize living cells or their components such as enzymes, bacteria, and others to obtain preferred products. The central idea behind the u …
- 銀ろう・金ろう（ろう付け材料）の世界市場About Silver- and Gold-Based Brazing Materials Brazing is the joining two or more metals by filling a molten filler metal, or a brazing alloy. The melting point of these alloys is usually above 840°F and below the melting temperature of the base metals that are to be joined. The base metals are heated to temperatures slightly above the liquidus temperature (temperature above which the metal liquid …
- 世界の塩素化ポリ塩化ビニル市場2015The Global Chlorinated Polyvinyl Chloride Industry Report 2015 is a professional and in-depth study on the current state of the CPVC industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The CPVC market analysis is provided for the international markets including development trends, competitive landscape an …
- グローバル運輸業界におけるITセキュリティソリューション市場（2014-2018）About IT Security Solutions in the Transportation Industry Transportation security refers to the physical and cyber securities implemented in mass transit locations such as railway stations, bus stations, airports, marine ports, and logistics. The need for security in these premises is very important because of the increasing unauthorized border crossing, and the transportation of arms and ammunit …
- インターポーザー及びファンアウト型WLPの世界市場予測（～2022年）“Interposer and fan-out WLP market to grow at a CAGR of 28.09% between 2016 and 2022”The interposer and fan-out WLP market has entered the growth phase and is expected to be valued at USD 13.42 billion in 2022, growing at a CAGR of 28.09% between 2016 and 2022. The major factors driving the growth of the market include rising trend of miniaturization of electronics devices; increasing demand for a …
- 石油・ガス業界のM&A及び投資動向（四半期別）：Q1 2013Oil & Gas Quarterly Deals Analysis: M&A and Investment Trends – Q1 2013 Summary GlobalData's “Oil & Gas Quarterly Deals Analysis: M&A and Investment Trends – Q1 2013” report is an essential source of data and trend analysis on mergers and acquisitions (M&As) and financings in the oil and gas industry. The report provides detailed information on M&As, equity/debt offerings, private equity (PE), ven …
- Knightsbridge Tankers Limited：石油・ガスバリューチェーン分析レポート2013Knightsbridge Tankers Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Knightsbridge Tankers Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Knightsbridge Tankers Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the v …
- 生体吸収性ステントの世界市場：材料（ポリマー、金属）、処置、吸収速度、薬品、用途、需要先、地域別分析The global bioabsorbable stents market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, fa …
- ヘルスケア製品向けコールドチェーン物流サービスの世界市場About Healthcare Cold Chain Logistics Market Healthcare cold chain logistics involves the transportation and distribution of pharmaceutical products that are temperature-sensitive. It helps the Healthcare industry increase the shelf life of various medicines and ensure uninterrupted supply of medicines, equipment, and devices from suppliers and distributors to different locations. TechNavio's anal …
- オーガニック食品･飲料の世界市場分析：製品別（果物･野菜、肉、魚･家禽、乳製品、冷凍･加工食品、オーガニック飲料（乳製品以外、コーヒー･紅茶、ビール･ワイン））、セグメント予測、2014-2025The global organic food & beverage market is expected to reach USD 320.5 billion by 2025, according to a new report by Grand View Research, Inc. Growing popularity of non-GMO products among consumers, owing to the health benefits associated with their consumption, is expected to drive the demand over the forecast period. Fruits and vegetables dominated the global organic food market accounted for …
- ルーマニアの風力発電市場2016：発電能力、生産、投資動向、制度、企業Wind Power in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles Summary "Wind Power in Romania, Market Outlook to 2030, Update 2016 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles” is the latest report from GlobalData, the industry ana …
- GIS（地理情報システム）の世界市場：GISソフトウェア、GISデータ、GISサービスTechnavio market research analyst predicts the global GIS market to grow steadily at a CAGR of more than 10% by 2020. The ability of geographic information systems (GIS) to enhance the end users' productivity, decision-making ability, and safety and security standards will result in its augmented adoption during the forecast period. Geographically, the Americas is expected to account for the larg …
- 動脈瘤コイリング及び塞栓装置の世界市場2019-2023About this market Technological advances in aneurysm coiling and embolization devices are likely to foster the market growth in the upcoming years. Innovative devices with novel designs and concepts are expected to ensure device delivery, thrombogenicity, safety, and occlusion durability. This has further led to the development of multi-dimensional, biologically inert, complex-shaped, soft, and st …
- 水溶性ポリマーの世界市場2019-2023About this market Access to fresh water has emerged as one of the most significant challenges in the face of expanding population worldwide. Consequently, the demand for clean water and wastewater treatment options is rapidly increasing around the world. Water-soluble polymers are used in wastewater treatment, sludge treatment and water purification applications. Water-soluble polymers such as pol …
- 清涼飲料販売機の世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Soft Drink Dispensers Market 2019-2023 Technavio recognizes the following companies as the key players in the global soft drink dispensers market: Cornelius, Inc, Lancer Corporation, Multiplex Beverage, PepsiCo, THE COCA-COLA COMPANY. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining moment …
